<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title></title></head><body><div><p style="margin:0pt"><span style="font-family:Arial; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written evidence from </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">T</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">he Royal College of Pathologists (</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">A</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">CQ 10)</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Summary of The Royal College of Pathologists’ written submission</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">The Care Quality Commission inspection regime</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The CQC has made major changes to its inspection regime. It now has a clear commitment to “regulate different services in different ways, making better use of tailored information and expert inspection to assess performance”. </span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">The role of The Royal College of Pathologists working with the CQC</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The Care Quality Commission commissioned The Royal College of Pathologists to assist with its investigation into oestrogen receptor (ER) testing at King’s Mill Hospital, part of Sherwood Forest Hospitals NHS Foundation Trust. (Breast cancer with a significant number of oestrogen receptors is known as oestrogen-receptor positive or ER positive. This is a predictive marker that drives clinical treatment decisions.) Seventy-nine women with breast cancer had been recalled by the Trust due to issues surrounding test results. The CQC report was published in April 2013 following a detailed review that looked into concerns about ER test results and quality assurance of these tests.</span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">This collaboration was the first of its kind for both organisations. We think such collaboration is essential if we are to understand the nature of sophisticated pathology tests, how their quality can be assured and how they support patients’ care. </span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">We think this model of collaboration is an important step in marshalling the expertise required. It could point to the development of a cost-effective route to an evidence-based approach for each sector that needs inspection or investigation by the CQC. This is vital when investigating complex diseases and conditions and specialist areas of practice.</span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The specialist </span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath</span><span style="font-family:'Times New Roman'; font-size:11pt"> review team was able to undertake an objective analysis of evidence about the quality of the service at King’s Mill Hospital and evaluate the quality of:</span><br /><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></li></ul><p style="margin:0pt 0pt 0pt 54pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">–</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">breast pathology reporting</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">–</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">laboratory processes and laboratory management</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">–</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">internal quality control and clinical governance procedures</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">–</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">external quality assurance processes and oversight.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Recent discussions with CQC’s Chief Inspectors for Hospitals and General Practice and Medical Director indicate that we should and can establish close working relationships between CQC and the College to ensure satisfactory surveillance of the quality of both the use of clinical pathology laboratory tests and the performance of these tests. This would be in collaboration with a number of other bodies, such as providers of schemes for external quality assurance and accreditation of pathology laboratories. </span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Feedback drawn from our work with the CQC</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It was clear that there was a high level of regulatory skills and ethical integrity amongst the CQC’s operational staff. We experience openness during our collaboration.</span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The CQC may not have enough staff for all the work expected of them and the complexities of specialist practice/range of medical specialties were not matched by the CQC staffs’ more generic regulatory skills. </span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Although the CQC has since introduced a more specialist approach to its investigations, there is still a need to call on a range of professional expertise. For example, the team drawn from the </span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath</span><span style="font-family:'Times New Roman'; font-size:11pt"> and the Institute of Biomedical Science for this investigation had experience in breast pathology, laboratory management, statistical analysis, quality assessment and service reviews, and clinical governance.</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">There are often weaknesses in initial internal, or internally commissioned, investigations into healthcare problems. The CQC standards should include all provider organisations to have training in place so that ten per cent of clinical and managerial staff in Case Investigation are trained and competent in Case Investigation and five per cent are trained and competent in Case Management. The recent National Clinical Assessment Service delivered training in these fields has had excellent feedback. Wider roll out of this would reap benefits in patient care, remediation and regulation of the healthcare sector.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 28.06pt; padding-left:25.94pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">This issue has resulted in two separate letters from Professor Sir Bruce Keogh</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Times New Roman'; font-size:11pt"> and the National Clinical Lead for Pathology, Professor Jo Martin,</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Times New Roman'; font-size:11pt"> which have been sent to all Trust Chief Executives, encouraging a more engaged and scientific approach to pathology quality.</span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">1</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">About The Royal College of Pathologists</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">1.1</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">The Royal College of Pathologists (</span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath</span><span style="font-family:'Times New Roman'; font-size:11pt">) is a professional membership organisation with charitable status. It is committed to setting and maintaining professional standards and to promoting excellence in the teaching and practice of pathology. </span><span style="font-family:'Times New Roman'; font-size:11pt">Pathology is the science at the heart of modern medicine and is involved in 70 per cent of all diagnoses made within the National Health Service. The College aims to advance the science and practice of pathology, to provide public education, to promote research in pathology and to disseminate the results. We have over 10,000 members across 19 </span><span style="font-family:'Times New Roman'; font-size:11pt">specialties </span><span style="font-family:'Times New Roman'; font-size:11pt">working in hospital laboratories, universities and industry worldwide to diagnose, treat and prevent illness.</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:6pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">2</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">              </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Introduction</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2.1</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">It has been recognised that major changes were needed to the inspection regime used by the Care Quality Commission (CQC). We welcome </span><span style="font-family:'Times New Roman'; font-size:11pt">the new posts of Chief Inspectors of Hospitals and General Practice and that their posts will be will be enshrined in law, so they are made permanent.</span><span style="font-family:'Times New Roman'; font-size:11pt"> We think the Chief Inspector of Hospitals, Professor Sir Mike Richards’ initiative to recruit more inspectors, including hospital patients and their carers, will provide a wider range of perspectives and give a voice to those who are treated by the NHS, helping to ensure safer, effective and compassionate care. </span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2.2</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">Nevertheless, it is vital that the CQC is supported to deploy health professionals with the expertise and experience to assess quality, standards and clinical governance across a range of complex and specialist areas. This must include prospective and retrospective assessment of quality. The CQC’s commitment to </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">“regulate different services in different ways, making better use of tailored information and expert inspection to assess performance”</span><span style="font-family:'Times New Roman'; font-size:11pt"> is an important step in ensuring there is the expertise available to make sure there is an evidence-based approach for each sector.</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2.3</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">In October 2012, the Care Quality Commission (CQC) carried out an inspection at King’s Mill Hospital, part of Sherwood Forest Hospitals NHS Foundation Trust, after 79 women with breast cancer were recalled by the Trust due to issues surrounding test results. Its report was published in April 2013, following a detailed inspection and review to look into concerns about the people with breast cancer whose treatment may have been based on incorrect test results. </span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:normal">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2.4</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">As part of the inspection, the </span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath</span><span style="font-family:'Times New Roman'; font-size:11pt"> was asked to provide specialist input to investigate concerns that the treatment of women with breast cancer between 2004 and 2011 may have been based on incorrect test results. </span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">suggested the additional involvement of the Institute of Biomedical Science (IBMS) and put together a review team with experience in breast pathology, laboratory management, statistical analysis, quality assessment and service reviews, and clinical governance. </span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">This collaboration was a first for both organisations; see our full report to the CQC.</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Times New Roman'; font-size:11pt"> We think this way of working is essential if the nature of sophisticated pathology tests, how their quality can be assured and how they support patients’ care is to be understood.</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2.5</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">The CQC’s inspection found that King’s Mill Hospital met the national standard concerning the care and welfare of people, but that processes to assess and assure the Trust of its own quality of service had not been sufficiently effective or robust.</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">2.6</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">Key findings before the </span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath</span><span style="font-family:'Times New Roman'; font-size:11pt"> was engaged were:</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 6pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">there had been poor communication between pathologists and the Trust’s Board of Directors, and weaknesses in communication between the Clinical Governance Committee and the Board of Directors</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 6pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">the pathology department was without a leader for five years between 2003 and 2007, with the role being covered by locum staff, and a number of permanent posts were not filled</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 6pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">equipment used by the department was identified as outdated and manual (rather than automated) techniques were used in the department, leading to inconsistent results</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 6pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">decision making in the Clinical Governance Committee was not always clear</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 6pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">the hospital’s action plan in relation to mortality rates was not being clearly monitored by the Trust’s Board and had not been subject to in-depth analysis</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 38.41pt; padding-left:18.29pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">processes to detect changes in performance or risk were not sufficiently robust.</span></li></ul><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="background-color:#ffffff; margin:6pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">3</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Detail of the investigation by </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">RCPath</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3.1</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">In order to get to the root of the problem, a collaborative approach to the investigation was agreed. A review team comprising specialist, expert pathologists led by the </span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath’s</span><span style="font-family:'Times New Roman'; font-size:11pt"> Professional Standards Unit, and including a representative of the IBMS, was set up to work on behalf of the Care Quality Commission. </span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3.2</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">This team investigated the complex issues relating to oestrogen receptor (ER) testing, the role of external quality assessment and the possible implications for other pathology services.</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3.3</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">The Care Quality Commission completed a ‘deep dive’ according to their procedures. The diagnostic and screening element of the investigation was deferred to the review team led by the </span><span style="font-family:'Times New Roman'; font-size:11pt">RCPath</span><span style="font-family:'Times New Roman'; font-size:11pt">. This review investigated diagnostic and screening procedures focussing on cellular pathology governance, breast reporting and </span><span style="font-family:'Times New Roman'; font-size:11pt">immunohistochemistry</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3.4</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">The team was asked to investigate these issues at King’s Mill Hospital, and related governance and oversight issues at the Trust and at regional and national levels. The investigation process consisted of a site visit, interviews, a slide review and a review of all documentation. In December 2012, members of the review team:</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 6pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">visited all pathology laboratories, including cellular pathology, and the mortuary</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 6pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">interviewed Trust staff and relevant regional and national individuals with knowledge of the issue, either on site or by telephone </span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 38.41pt; padding-left:18.29pt; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">reviewed all of the cases identified by King’s Mill Hospital as ‘ER negative’ from 2006 to 2010 that had been retested. Slides from the retests carried out at Cambridge were also reviewed.</span></li></ul><p style="background-color:#ffffff; margin:0pt 0pt 0pt 56.7pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">3.5</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">The findings of the report had implications wider than for King’s Mill Hospital alone. It raised questions about the organisation of pathology departments and their workload, and the effectiveness of pathology quality assurance. </span></p><p style="margin:6pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">4</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Feedback drawn from our work with the CQC</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">4.1</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">First, the high level of regulatory skills and ethical integrity of the CQC’s operational staff were clear. We experience openness during our collaboration. </span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">4.2</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">Second, the CQC may not have enough staff for all the work expected of them and the complexities of specialist care were not matched by the CQC staffs’ more generic regulatory skills. Although the CQC has since introduced a more specialist approach to its investigations, it would still seem that they would need to call on a range of professional expertise. For example, for this investigation the team had experience in breast pathology, laboratory management, statistical analysis, quality assessment and service reviews, and clinical governance. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">4.3</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">This collaboration was the first of its kind for both organisations. We think such collaboration is essential if we are to understand the nature of sophisticated pathology tests, how their quality can be assured and how they support patients’ care. </span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">4.</span><span style="font-family:'Times New Roman'; font-size:11pt">4</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">We think this model of collaboration is an important step in marshalling the expertise required and could point to the development of a cost-effective route to make sure there is an evidence-based approach for each sector that needs inspection or investigation by the CQC. This is vital when investigating complex diseases and conditions and specialist areas of practice</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">4.</span><span style="font-family:'Times New Roman'; font-size:11pt">5</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">There are often weaknesses in initial internal, or internally commissioned, investigations into healthcare problems. The CQC standards should include all provider organisations to have training in place so that ten per cent of clinical and managerial staff in Case Investigation are trained and competent in Case Investigation and five per cent are trained and competent in Case Management. The recent National Clinical Assessment Service delivered training in these fields has had excellent feedback. Wider roll out of this would reap benefits in patient care, remediation and regulation of the healthcare sector.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">4.</span><span style="font-family:'Times New Roman'; font-size:11pt">6</span><span style="font-family:'Times New Roman'; font-size:11pt">              </span><span style="font-family:'Times New Roman'; font-size:11pt">This issue has resulted in two separate letters from Professor Sir Bruce Keogh</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a><span style="font-family:'Times New Roman'; font-size:11pt"> and the National Clinical Lead for Pathology, Professor Jo Martin,</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Times New Roman'; font-size:11pt"> which have been sent to all Trust Chief Executives, encouraging a more engaged and scientific approach to pathology quality. </span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 28.35pt; text-align:justify; text-indent:-28.35pt"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">October 2013</span></p><p style="margin:0pt"><span style="font-family:Arial; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:Arial; font-size:11pt">&#xa0;</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:'Times New Roman'; font-size:9pt"> https://www.gov.uk/government/news/pathology-quality-assurance-review-launched</span></p><p style="margin:0pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:'Times New Roman'; font-size:10pt"> </span><span style="font-family:'Times New Roman'; font-size:9pt">http://www.england.nhs.uk/wp-content/uploads/2013/07/receptor-test-let.pdf</span></p><p style="margin:0pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:'Times New Roman'; font-size:9pt"> http://www.rcpath.org/Resources/PDF/Kings%20Mill%20RCPath%20CQC%20report%205%20April.pdf</span></p><p style="margin:0pt"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> https://www.gov.uk/government/news/pathology-quality-assurance-review-launched</span></p><p style="margin:0pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.england.nhs.uk/wp-content/uploads/2013/07/receptor-test-let.pdf</span></p></body></html>